MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

<div>MET expression in low and high Fuhrman grade tumors (1/2 versus 3/4).<i> t</i>-test was used to compare the means of MET expression (AQUA scores) in “low” (1 and 2) versus “high” (3 and 4) Fuhrman grade tumors (<i>P</i> = 0.019).</div>

BioMed Research International

fig2

Figure 2

Figure 2: MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors 

Figure 2 | MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors 